Human Genome Sciences (HGSI -7.5%) tumbles after an earnings miss, but Leerink Swann's Joseph...

|By:, SA News Editor

Human Genome Sciences (HGSI -7.5%) tumbles after an earnings miss, but Leerink Swann's Joseph Schwartz says the sell-off is overdone. "We think the numbers going forward are very achievable and would use weakness as buying opportunity," the analyst says.